These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3669762

  • 1. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
    Huber C, Aulitzky W, Tilg H, von Lüttichau I, Troppmair J, Nachbauer K, Gastl G.
    Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
    [Abstract] [Full Text] [Related]

  • 2. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G, Werter M, De Pauw B, Nerl C, Aulitzky W, von Lüttichau I, Tilg H, Thaler J, Lang A, Abbrederis K.
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [Abstract] [Full Text] [Related]

  • 3. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD, Cawley JC.
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [Abstract] [Full Text] [Related]

  • 4. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W, Gastl G, Tilg H, Troppmair J, Leiter E, Geissler D, Flener R, Huber C.
    Wien Med Wochenschr; 1986 Apr 30; 136(7-8):172-81. PubMed ID: 3524022
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
    Vedantham S, Gamliel H, Golomb HM.
    Cancer Res; 1992 Mar 01; 52(5):1056-66. PubMed ID: 1737364
    [Abstract] [Full Text] [Related]

  • 12. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
    Liberati AM, Schippa M, Portuesi MG, Grazia Proietti M, De Angelis V, Ferrajoli A, Cinieri S, Di Clemente F, Palmisano L, Berruto P.
    Haematologica; 1991 Mar 01; 76(5):375-82. PubMed ID: 1806440
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
    Wagner L, Goldstone AH, Worman CP.
    Leukemia; 1989 May 01; 3(5):373-9. PubMed ID: 2497282
    [Abstract] [Full Text] [Related]

  • 14. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D, Levo Y, Rahmani R, Mory Y, Vaks B, Horowitz O, Doerner T, Shoham J, Wallach D, Revel M.
    Isr J Med Sci; 1985 Dec 01; 21(12):977-81. PubMed ID: 4093298
    [Abstract] [Full Text] [Related]

  • 15. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M, Rolović Z, Vuković S, Elezović I, Tomić D.
    Srp Arh Celok Lek; 1990 Dec 01; 118(7-8):277-84. PubMed ID: 2097776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF, Estey EH, Keating MJ, Kurzrock R.
    Leukemia; 1995 May 01; 9(5):929-32. PubMed ID: 7769859
    [Abstract] [Full Text] [Related]

  • 19. [The therapeutic effect of interferon-alpha exemplified by hairy cell leukemia].
    Schwarzmeier JD.
    Wien Med Wochenschr; 1993 May 01; 143(16-17):412-5. PubMed ID: 8273363
    [Abstract] [Full Text] [Related]

  • 20. Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters.
    Hiraoka A, Golomb HM.
    J Biol Response Mod; 1986 Jun 01; 5(3):270-81. PubMed ID: 3723140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.